Loading...
Header Logo
Keywords
Last Name
Institution

LOUISE C STRONG

TitleProfessor
InstitutionMD Anderson
DepartmentGenetics
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Shin SJ, Li J, Ning J, Bojadzieva J, Strong LC, Wang W. Bayesian estimation of a semiparametric recurrent event model with applications to the penetrance estimation of multiple primary cancers in Li-Fraumeni syndrome. Biostatistics. 2020 Jul 01; 21(3):467-482. PMID: 30445420.
      View in: PubMed
    2. Mai PL, Sand SR, Saha N, Oberti M, Dolafi T, DiGianni L, Root EJ, Kong X, Bremer RC, Santiago KM, Bojadzieva J, Barley D, Novokmet A, Ketchum KA, Nguyen N, Jacob S, Nichols KE, Kratz CP, Schiffman JD, Evans DG, Achatz MI, Strong LC, Garber JE, Ladwa SA, Malkin D, Weitzel JN. Li-Fraumeni Exploration Consortium Data Coordinating Center: Building an Interactive Web-Based Resource for Collaborative International Cancer Epidemiology Research for a Rare Condition. Cancer Epidemiol Biomarkers Prev. 2020 May; 29(5):927-935. PMID: 32156722.
      View in: PubMed
    3. Shin SJ, Dodd-Eaton EB, Gao F, Bojadzieva J, Chen J, Kong X, Amos CI, Ning J, Strong LC, Wang W. Penetrance Estimates Over Time to First and Second Primary Cancer Diagnosis in Families with Li-Fraumeni Syndrome: A Single Institution Perspective. Cancer Res. 2020 01 15; 80(2):347-353. PMID: 31719099.
      View in: PubMed
    4. Shin SJ, Dodd-Eaton EB, Peng G, Bojadzieva J, Chen J, Amos CI, Frone MN, Khincha PP, Mai PL, Savage SA, Ballinger ML, Thomas DM, Yuan Y, Strong LC, Wang W. Penetrance of Different Cancer Types in Families with Li-Fraumeni Syndrome: A Validation Study Using Multicenter Cohorts. Cancer Res. 2020 01 15; 80(2):354-360. PMID: 31719101.
      View in: PubMed
    5. Swaminathan M, Bannon SA, Routbort M, Naqvi K, Kadia TM, Takahashi K, Alvarado Y, Ravandi-Kashani F, Patel KP, Champlin R, Kantarjian H, Strong L, DiNardo CD. Hematologic malignancies and Li-Fraumeni syndrome. Cold Spring Harb Mol Case Stud. 2019 02; 5(1). PMID: 30709875.
      View in: PubMed
    6. Opstal-van Winden AWJ, de Haan HG, Hauptmann M, Schmidt MK, Broeks A, Russell NS, Janus CPM, Krol ADG, van der Baan FH, De Bruin ML, van Eggermond AM, Dennis J, Anton-Culver H, Haiman CA, Sawyer EJ, Cox A, Devilee P, Hooning MJ, Peto J, Couch FJ, Pharoah P, Orr N, Easton DF, Aleman BMP, Strong LC, Bhatia S, Cooke R, Robison LL, Swerdlow AJ, van Leeuwen FE. Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma. Blood. 2019 03 07; 133(10):1130-1139. PMID: 30573632.
      View in: PubMed
    7. Shin SJ, Yuan Y, Strong LC, Bojadzieva J, Wang W. Bayesian Semiparametric Estimation of Cancer-specific Age-at-onset Penetrance with Application to Li-Fraumeni Syndrome. J Am Stat Assoc. 2019; 114(526):541-552. PMID: 31485091.
      View in: PubMed
    8. Bojadzieva J, Amini B, Day SF, Jackson TL, Thomas PS, Willis BJ, Throckmorton WR, Daw NC, Bevers TB, Strong LC. Whole body magnetic resonance imaging (WB-MRI) and brain MRI baseline surveillance in TP53 germline mutation carriers: experience from the Li-Fraumeni Syndrome Education and Early Detection (LEAD) clinic. Fam Cancer. 2018 04; 17(2):287-294. PMID: 28988289.
      View in: PubMed
    9. Ballinger ML, Best A, Mai PL, Khincha PP, Loud JT, Peters JA, Achatz MI, Chojniak R, Balieiro da Costa A, Santiago KM, Garber J, O'Neill AF, Eeles RA, Evans DG, Bleiker E, Sonke GS, Ruijs M, Loo C, Schiffman J, Naumer A, Kohlmann W, Strong LC, Bojadzieva J, Malkin D, Rednam SP, Stoffel EM, Koeppe E, Weitzel JN, Slavin TP, Nehoray B, Robson M, Walsh M, Manelli L, Villani A, Thomas DM, Savage SA. Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging: A Meta-analysis. JAMA Oncol. 2017 12 01; 3(12):1634-1639. PMID: 28772291.
      View in: PubMed
    10. Goldsby RE, Stratton KL, Raber S, Ablin A, Strong LC, Oeffinger K, Sklar CA, Armstrong GT, Robison LL, Bhatia S, Leisenring WM. Long-term sequelae in survivors of childhood leukemia with Down syndrome: A childhood cancer survivor study report. Cancer. 2018 02 01; 124(3):617-625. PMID: 29105081.
      View in: PubMed
    11. Morton LM, Sampson JN, Armstrong GT, Chen TH, Hudson MM, Karlins E, Dagnall CL, Li SA, Wilson CL, Srivastava DK, Liu W, Kang G, Oeffinger KC, Henderson TO, Moskowitz CS, Gibson TM, Merino DM, Wong JR, Hammond S, Neglia JP, Turcotte LM, Miller J, Bowen L, Wheeler WA, Leisenring WM, Whitton JA, Burdette L, Chung C, Hicks BD, Jones K, Machiela MJ, Vogt A, Wang Z, Yeager M, Neale G, Lear M, Strong LC, Yasui Y, Stovall M, Weathers RE, Smith SA, Howell R, Davies SM, Radloff GA, Onel K, Berrington de González A, Inskip PD, Rajaraman P, Fraumeni JF, Bhatia S, Chanock SJ, Tucker MA, Robison LL. Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer. J Natl Cancer Inst. 2017 11 01; 109(11). PMID: 29059430.
      View in: PubMed
    12. Daniels M, Wathoo C, Brusco L, Lu KH, Shaw K, Dumbrava EEI, Arun B, Strong L, Litton JK, Eterovic K, Aytac U, Mendelsohn J, Mills GB, Chen K, Meric-Bernstam F. Active Disclosure of Secondary Germline Findings to Deceased Research Participants' Personal Representatives: Process and Outcomes. JCO Precis Oncol. 2017; 1. PMID: 31552380.
      View in: PubMed
    13. Zhou R, Xu A, Gingold J, Strong LC, Zhao R, Lee DF. Li-Fraumeni Syndrome Disease Model: A Platform to Develop Precision Cancer Therapy Targeting Oncogenic p53. Trends Pharmacol Sci. 2017 10; 38(10):908-927. PMID: 28818333.
      View in: PubMed
    14. Kratz CP, Achatz MI, Brugières L, Frebourg T, Garber JE, Greer MC, Hansford JR, Janeway KA, Kohlmann WK, McGee R, Mullighan CG, Onel K, Pajtler KW, Pfister SM, Savage SA, Schiffman JD, Schneider KA, Strong LC, Evans DGR, Wasserman JD, Villani A, Malkin D. Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome. Clin Cancer Res. 2017 06 01; 23(11):e38-e45. PMID: 28572266.
      View in: PubMed
    15. Porter CC, Druley TE, Erez A, Kuiper RP, Onel K, Schiffman JD, Wolfe Schneider K, Scollon SR, Scott HS, Strong LC, Walsh MF, Nichols KE. Recommendations for Surveillance for Children with Leukemia-Predisposing Conditions. Clin Cancer Res. 2017 Jun 01; 23(11):e14-e22. PMID: 28572263.
      View in: PubMed
    16. Ross J, Bojadzieva J, Peterson S, Noblin SJ, Yzquierdo R, Askins M, Strong L. The psychosocial effects of the Li-Fraumeni Education and Early Detection (LEAD) program on individuals with Li-Fraumeni syndrome. Genet Med. 2017 09; 19(9):1064-1070. PMID: 28301458.
      View in: PubMed
    17. Leroy B, Ballinger ML, Baran-Marszak F, Bond GL, Braithwaite A, Concin N, Donehower LA, El-Deiry WS, Fenaux P, Gaidano G, Langerød A, Hellstrom-Lindberg E, Iggo R, Lehmann-Che J, Mai PL, Malkin D, Moll UM, Myers JN, Nichols KE, Pospisilova S, Ashton-Prolla P, Rossi D, Savage SA, Strong LC, Tonin PN, Zeillinger R, Zenz T, Fraumeni JF, Taschner PE, Hainaut P, Soussi T. Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice. Cancer Res. 2017 03 15; 77(6):1250-1260. PMID: 28254861.
      View in: PubMed
    18. Peng G, Bojadzieva J, Ballinger ML, Li J, Blackford AL, Mai PL, Savage SA, Thomas DM, Strong LC, Wang W. Estimating TP53 Mutation Carrier Probability in Families with Li-Fraumeni Syndrome Using LFSPRO. Cancer Epidemiol Biomarkers Prev. 2017 06; 26(6):837-844. PMID: 28137790.
      View in: PubMed
    19. Malkin D, Garber JE, Strong LC, Friend SH. CANCER. The cancer predisposition revolution. Science. 2016 May 27; 352(6289):1052-3. PMID: 27230363.
      View in: PubMed
    20. Henderson TO, Moskowitz CS, Chou JF, Bradbury AR, Neglia JP, Dang CT, Onel K, Novetsky Friedman D, Bhatia S, Strong LC, Stovall M, Kenney LB, Barnea D, Lorenzi E, Hammond S, Leisenring WM, Robison LL, Armstrong GT, Diller LR, Oeffinger KC. Breast Cancer Risk in Childhood Cancer Survivors Without a History of Chest Radiotherapy: A Report From the Childhood Cancer Survivor Study. J Clin Oncol. 2016 Mar 20; 34(9):910-8. PMID: 26700127.
      View in: PubMed
    21. Palculict TB, Ruteshouser EC, Fan Y, Wang W, Strong L, Huff V. Identification of germline DICER1 mutations and loss of heterozygosity in familial Wilms tumour. J Med Genet. 2016 06; 53(6):385-8. PMID: 26566882.
      View in: PubMed
    22. Tefferi A, Kantarjian H, Rajkumar SV, Baker LH, Abkowitz JL, Adamson JW, Advani RH, Allison J, Antman KH, Bast RC, Bennett JM, Benz EJ, Berliner N, Bertino J, Bhatia R, Bhatia S, Bhojwani D, Blanke CD, Bloomfield CD, Bosserman L, Broxmeyer HE, Byrd JC, Cabanillas F, Canellos GP, Chabner BA, Chanan-Khan A, Cheson B, Clarkson B, Cohn SL, Colon-Otero G, Cortes J, Coutre S, Cristofanilli M, Curran WJ, Daley GQ, DeAngelo DJ, Deeg HJ, Einhorn LH, Erba HP, Esteva FJ, Estey E, Fidler IJ, Foran J, Forman S, Freireich E, Fuchs C, George JN, Gertz MA, Giralt S, Golomb H, Greenberg P, Gutterman J, Handin RI, Hellman S, Hoff PM, Hoffman R, Hong WK, Horowitz M, Hortobagyi GN, Hudis C, Issa JP, Johnson BE, Kantoff PW, Kaushansky K, Khayat D, Khuri FR, Kipps TJ, Kripke M, Kyle RA, Larson RA, Lawrence TS, Levine R, Link MP, Lippman SM, Lonial S, Lyman GH, Markman M, Mendelsohn J, Meropol NJ, Messinger Y, Mulvey TM, O'Brien S, Perez-Soler R, Pollock R, Prchal J, Press O, Radich J, Rai K, Rosenberg SA, Rowe JM, Rugo H, Runowicz CD, Sandmaier BM, Saven A, Schafer AI, Schiffer C, Sekeres MA, Silver RT, Siu LL, Steensma DP, Stewart FM, Stock W, Stone R, Storb R, Strong LC, Tallman MS, Thompson M, Ueno NT, Van Etten RA, Vose JM, Wiernik PH, Winer EP, Younes A, Zelenetz AD, LeMaistre CA. In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs. Mayo Clin Proc. 2015 Aug; 90(8):996-1000. PMID: 26211600.
      View in: PubMed
    23. Yang XR, Killian JK, Hammond S, Burke LS, Bennett H, Wang Y, Davis SR, Strong LC, Neglia J, Stovall M, Weathers RE, Robison LL, Bhatia S, Mabuchi K, Inskip PD, Meltzer P. Characterization of genomic alterations in radiation-associated breast cancer among childhood cancer survivors, using comparative genomic hybridization (CGH) arrays. PLoS One. 2015; 10(3):e0116078. PMID: 25764003.
      View in: PubMed
    24. Hill DA, Horick NK, Isaacs C, Domchek SM, Tomlinson GE, Lowery JT, Kinney AY, Berg JS, Edwards KL, Moorman PG, Plon SE, Strong LC, Ziogas A, Griffin CA, Kasten CH, Finkelstein DM. Long-term risk of medical conditions associated with breast cancer treatment. Breast Cancer Res Treat. 2014 May; 145(1):233-43. PMID: 24696430.
      View in: PubMed
    25. Gramatges MM, Liu Q, Yasui Y, Okcu MF, Neglia JP, Strong LC, Armstrong GT, Robison LL, Bhatia S. Telomere content and risk of second malignant neoplasm in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Clin Cancer Res. 2014 Feb 15; 20(4):904-11. PMID: 24277454.
      View in: PubMed
    26. Pilarski R, Cebulla CM, Massengill JB, Rai K, Rich T, Strong L, McGillivray B, Asrat MJ, Davidorf FH, Abdel-Rahman MH. Expanding the clinical phenotype of hereditary BAP1 cancer predisposition syndrome, reporting three new cases. Genes Chromosomes Cancer. 2014 Feb; 53(2):177-82. PMID: 24243779.
      View in: PubMed
    27. Wang PY, Ma W, Park JY, Celi FS, Arena R, Choi JW, Ali QA, Tripodi DJ, Zhuang J, Lago CU, Strong LC, Talagala SL, Balaban RS, Kang JG, Hwang PM. Increased oxidative metabolism in the Li-Fraumeni syndrome. N Engl J Med. 2013 Mar 14; 368(11):1027-32. PMID: 23484829.
      View in: PubMed
    28. Powell BC, Jiang L, Muzny DM, Treviño LR, Dreyer ZE, Strong LC, Wheeler DA, Gibbs RA, Plon SE. Identification of TP53 as an acute lymphocytic leukemia susceptibility gene through exome sequencing. Pediatr Blood Cancer. 2013 Jun; 60(6):E1-3. PMID: 23255406.
      View in: PubMed
    29. Mai PL, Malkin D, Garber JE, Schiffman JD, Weitzel JN, Strong LC, Wyss O, Locke L, Means V, Achatz MI, Hainaut P, Frebourg T, Evans DG, Bleiker E, Patenaude A, Schneider K, Wilfond B, Peters JA, Hwang PM, Ford J, Tabori U, Ognjanovic S, Dennis PA, Wentzensen IM, Greene MH, Fraumeni JF, Savage SA. Li-Fraumeni syndrome: report of a clinical research workshop and creation of a research consortium. Cancer Genet. 2012 Oct; 205(10):479-87. PMID: 22939227.
      View in: PubMed
    30. Cozen W, Li D, Best T, Van Den Berg DJ, Gourraud PA, Cortessis VK, Skol AD, Mack TM, Glaser SL, Weiss LM, Nathwani BN, Bhatia S, Schumacher FR, Edlund CK, Hwang AE, Slager SL, Fredericksen ZS, Strong LC, Habermann TM, Link BK, Cerhan JR, Robison LL, Conti DV, Onel K. A genome-wide meta-analysis of nodular sclerosing Hodgkin lymphoma identifies risk loci at 6p21.32. Blood. 2012 Jan 12; 119(2):469-75. PMID: 22086417.
      View in: PubMed
    31. Neklason DW, Done MW, Sargent NR, Schwartz AG, Anton-Culver H, Griffin CA, Ahnen DJ, Schildkraut JM, Tomlinson GE, Strong LC, Miller AR, Stopfer JE, Burt RW. Activating mutation in MET oncogene in familial colorectal cancer. BMC Cancer. 2011 Oct 04; 11:424. PMID: 21970370.
      View in: PubMed
    32. DuBois SG, Goldsby R, Segal M, Woo J, Copren K, Kane JP, Pullinger CR, Matthay KK, Witte J, Lessnick SL, Robison LL, Bhatia S, Strong LC. Evaluation of polymorphisms in EWSR1 and risk of Ewing sarcoma: a report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer. 2012 Jul 15; 59(1):52-6. PMID: 21793187.
      View in: PubMed
    33. Best T, Li D, Skol AD, Kirchhoff T, Jackson SA, Yasui Y, Bhatia S, Strong LC, Domchek SM, Nathanson KL, Olopade OI, Huang RS, Mack TM, Conti DV, Offit K, Cozen W, Robison LL, Onel K. Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma. Nat Med. 2011 Jul 24; 17(8):941-3. PMID: 21785431.
      View in: PubMed
    34. Melhem-Bertrandt A, Bojadzieva J, Ready KJ, Obeid E, Liu DD, Gutierrez-Barrera AM, Litton JK, Olopade OI, Hortobagyi GN, Strong LC, Arun BK. Early onset HER2-positive breast cancer is associated with germline TP53 mutations. Cancer. 2012 Feb 15; 118(4):908-13. PMID: 21761402.
      View in: PubMed
    35. Ziogas A, Horick NK, Kinney AY, Lowery JT, Domchek SM, Isaacs C, Griffin CA, Moorman PG, Edwards KL, Hill DA, Berg JS, Tomlinson GE, Anton-Culver H, Strong LC, Kasten CH, Finkelstein DM, Plon SE. Clinically relevant changes in family history of cancer over time. JAMA. 2011 Jul 13; 306(2):172-8. PMID: 21750294.
      View in: PubMed
    36. Fang S, Krahe R, Bachinski LL, Zhang B, Amos CI, Strong LC. Sex-specific effect of the TP53 PIN3 polymorphism on cancer risk in a cohort study of TP53 germline mutation carriers. Hum Genet. 2011 Dec; 130(6):789-94. PMID: 21688173.
      View in: PubMed
    37. Wu CC, Krahe R, Lozano G, Zhang B, Wilson CD, Jo EJ, Amos CI, Shete S, Strong LC. Joint effects of germ-line TP53 mutation, MDM2 SNP309, and gender on cancer risk in family studies of Li-Fraumeni syndrome. Hum Genet. 2011 Jun; 129(6):663-73. PMID: 21305319.
      View in: PubMed
    38. Plon SE, Wheeler DA, Strong LC, Tomlinson GE, Pirics M, Meng Q, Cheung HC, Begin PR, Muzny DM, Lewis L, Biegel JA, Gibbs RA. Identification of genetic susceptibility to childhood cancer through analysis of genes in parallel. Cancer Genet. 2011 Jan; 204(1):19-25. PMID: 21356188.
      View in: PubMed
    39. Hu Q, Gao F, Tian W, Ruteshouser EC, Wang Y, Lazar A, Stewart J, Strong LC, Behringer RR, Huff V. Wt1 ablation and Igf2 upregulation in mice result in Wilms tumors with elevated ERK1/2 phosphorylation. J Clin Invest. 2011 Jan; 121(1):174-83. PMID: 21123950.
      View in: PubMed
    40. Talwalkar SS, Yin CC, Naeem RC, Hicks MJ, Strong LC, Abruzzo LV. Myelodysplastic syndromes arising in patients with germline TP53 mutation and Li-Fraumeni syndrome. Arch Pathol Lab Med. 2010 Jul; 134(7):1010-5. PMID: 20586629.
      View in: PubMed
    41. Fang S, Krahe R, Lozano G, Han Y, Chen W, Post SM, Zhang B, Wilson CD, Bachinski LL, Strong LC, Amos CI. Effects of MDM2, MDM4 and TP53 codon 72 polymorphisms on cancer risk in a cohort study of carriers of TP53 germline mutations. PLoS One. 2010 May 26; 5(5):e10813. PMID: 20520810.
      View in: PubMed
    42. Wu CC, Strong LC, Shete S. Effects of measured susceptibility genes on cancer risk in family studies. Hum Genet. 2010 Mar; 127(3):349-57. PMID: 20039063.
      View in: PubMed
    43. Robison LL, Armstrong GT, Boice JD, Chow EJ, Davies SM, Donaldson SS, Green DM, Hammond S, Meadows AT, Mertens AC, Mulvihill JJ, Nathan PC, Neglia JP, Packer RJ, Rajaraman P, Sklar CA, Stovall M, Strong LC, Yasui Y, Zeltzer LK. The Childhood Cancer Survivor Study: a National Cancer Institute-supported resource for outcome and intervention research. J Clin Oncol. 2009 May 10; 27(14):2308-18. PMID: 19364948.
      View in: PubMed
    44. Neklason DW, Kerber RA, Nilson DB, Anton-Culver H, Schwartz AG, Griffin CA, Lowery JT, Schildkraut JM, Evans JP, Tomlinson GE, Strong LC, Miller AR, Stopfer JE, Finkelstein DM, Nadkarni PM, Kasten CH, Mineau GP, Burt RW. Common familial colorectal cancer linked to chromosome 7q31: a genome-wide analysis. Cancer Res. 2008 Nov 01; 68(21):8993-7. PMID: 18974144.
      View in: PubMed
    45. Peterson SK, Pentz RD, Marani SK, Ward PA, Blanco AM, LaRue D, Vogel K, Solomon T, Strong LC. Psychological functioning in persons considering genetic counseling and testing for Li-Fraumeni syndrome. Psychooncology. 2008 Aug; 17(8):783-9. PMID: 18688785.
      View in: PubMed
    46. Mulrooney DA, Dover DC, Li S, Yasui Y, Ness KK, Mertens AC, Neglia JP, Sklar CA, Robison LL, Davies SM. Twenty years of follow-up among survivors of childhood and young adult acute myeloid leukemia: a report from the Childhood Cancer Survivor Study. Cancer. 2008 May 01; 112(9):2071-9. PMID: 18327823.
      View in: PubMed
    47. Atwal GS, Rabadán R, Lozano G, Strong LC, Ruijs MW, Schmidt MK, van't Veer LJ, Nevanlinna H, Tommiska J, Aittomäki K, Bougeard G, Frebourg T, Levine AJ, Bond GL. An information-theoretic analysis of genetics, gender and age in cancer patients. PLoS One. 2008 Apr 09; 3(4):e1951. PMID: 18398474.
      View in: PubMed
    48. Kleinbaum EP, Lazar AJ, Tamborini E, Mcauliffe JC, Sylvestre PB, Sunnenberg TD, Strong L, Chen LL, Choi H, Benjamin RS, Zhang W, Trent JC. Clinical, histopathologic, molecular and therapeutic findings in a large kindred with gastrointestinal stromal tumor. Int J Cancer. 2008 Feb 01; 122(3):711-8. PMID: 17943734.
      View in: PubMed
    49. Parmigiani G, Chen S, Iversen ES, Friebel TM, Finkelstein DM, Anton-Culver H, Ziogas A, Weber BL, Eisen A, Malone KE, Daling JR, Hsu L, Ostrander EA, Peterson LE, Schildkraut JM, Isaacs C, Corio C, Leondaridis L, Tomlinson G, Amos CI, Strong LC, Berry DA, Weitzel JN, Sand S, Dutson D, Kerber R, Peshkin BN, Euhus DM. Validity of models for predicting BRCA1 and BRCA2 mutations. Ann Intern Med. 2007 Oct 02; 147(7):441-50. PMID: 17909205.
      View in: PubMed
    50. Henderson TO, Whitton J, Stovall M, Mertens AC, Mitby P, Friedman D, Strong LC, Hammond S, Neglia JP, Meadows AT, Robison L, Diller L. Secondary sarcomas in childhood cancer survivors: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2007 Feb 21; 99(4):300-8. PMID: 17312307.
      View in: PubMed
    51. Uyei A, Peterson SK, Erlichman J, Broglio K, Yekell S, Schmeler K, Lu K, Meric-Bernstam F, Amos C, Strong L, Arun B. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study. Cancer. 2006 Dec 15; 107(12):2745-51. PMID: 17109443.
      View in: PubMed
    52. Wu CC, Shete S, Amos CI, Strong LC. Joint effects of germ-line p53 mutation and sex on cancer risk in Li-Fraumeni syndrome. Cancer Res. 2006 Aug 15; 66(16):8287-92. PMID: 16912210.
      View in: PubMed
    53. Peterson SK, Pentz RD, Blanco AM, Ward PA, Watts BG, Marani SK, James LC, Strong LC. Evaluation of a decision aid for families considering p53 genetic counseling and testing. Genet Med. 2006 Apr; 8(4):226-33. PMID: 16617243.
      View in: PubMed
    54. Kadan-Lottick NS, Kawashima T, Tomlinson G, Friedman DL, Yasui Y, Mertens AC, Robison LL, Strong LC. The risk of cancer in twins: a report from the childhood cancer survivor study. Pediatr Blood Cancer. 2006 Apr; 46(4):476-81. PMID: 16078231.
      View in: PubMed
    55. Chen S, Iversen ES, Friebel T, Finkelstein D, Weber BL, Eisen A, Peterson LE, Schildkraut JM, Isaacs C, Peshkin BN, Corio C, Leondaridis L, Tomlinson G, Dutson D, Kerber R, Amos CI, Strong LC, Berry DA, Euhus DM, Parmigiani G. Characterization of BRCA1 and BRCA2 mutations in a large United States sample. J Clin Oncol. 2006 Feb 20; 24(6):863-71. PMID: 16484695.
      View in: PubMed
    56. Barcenas CH, Hosain GM, Arun B, Zong J, Zhou X, Chen J, Cortada JM, Mills GB, Tomlinson GE, Miller AR, Strong LC, Amos CI. Assessing BRCA carrier probabilities in extended families. J Clin Oncol. 2006 Jan 20; 24(3):354-60. PMID: 16421416.
      View in: PubMed
    57. Travis LB, Rabkin CS, Brown LM, Allan JM, Alter BP, Ambrosone CB, Begg CB, Caporaso N, Chanock S, DeMichele A, Figg WD, Gospodarowicz MK, Hall EJ, Hisada M, Inskip P, Kleinerman R, Little JB, Malkin D, Ng AK, Offit K, Pui CH, Robison LL, Rothman N, Shields PG, Strong L, Taniguchi T, Tucker MA, Greene MH. Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendations. J Natl Cancer Inst. 2006 Jan 04; 98(1):15-25. PMID: 16391368.
      View in: PubMed
    58. Matthews AG, Betensky RA, Anton-Culver H, Bowen D, Griffin C, Isaacs C, Kasten C, Mineau G, Nayfield S, Schildkraut J, Strong L, Weber B, Finkelstein DM. Analysis of co-aggregation of cancer based on registry data. Community Genet. 2006; 9(2):87-92. PMID: 16612058.
      View in: PubMed
    59. Robison LL, Green DM, Hudson M, Meadows AT, Mertens AC, Packer RJ, Sklar CA, Strong LC, Yasui Y, Zeltzer LK. Long-term outcomes of adult survivors of childhood cancer. Cancer. 2005 Dec 01; 104(11 Suppl):2557-64. PMID: 16247780.
      View in: PubMed
    60. Brown BW, Costello TJ, Hwang SJ, Strong LC. Generation or birth cohort effect on cancer risk in Li-Fraumeni syndrome. Hum Genet. 2005 Dec; 118(3-4):489-98. PMID: 16284780.
      View in: PubMed
    61. Ju Z, Kapoor M, Newton K, Cheon K, Ramaswamy A, Lotan R, Strong LC, Koo JS. Global detection of molecular changes reveals concurrent alteration of several biological pathways in nonsmall cell lung cancer cells. Mol Genet Genomics. 2005 Sep; 274(2):141-54. PMID: 16049682.
      View in: PubMed
    62. Friedman DL, Kadan-Lottick NS, Whitton J, Mertens AC, Yasui Y, Liu Y, Meadows AT, Robison LL, Strong LC. Increased risk of cancer among siblings of long-term childhood cancer survivors: a report from the childhood cancer survivor study. Cancer Epidemiol Biomarkers Prev. 2005 Aug; 14(8):1922-7. PMID: 16103438.
      View in: PubMed
    63. Bachinski LL, Olufemi SE, Zhou X, Wu CC, Yip L, Shete S, Lozano G, Amos CI, Strong LC, Krahe R. Genetic mapping of a third Li-Fraumeni syndrome predisposition locus to human chromosome 1q23. Cancer Res. 2005 Jan 15; 65(2):427-31. PMID: 15695383.
      View in: PubMed
    64. Patterson A, Davis H, Euhus D, Neuhausen S, Strong L, Tomlinson G. Recruitment for breast cancer predisposition studies in an underserved African American population. Breast J. 2005 Jan-Feb; 11(1):79-82. PMID: 15647088.
      View in: PubMed
    65. Lang GA, Iwakuma T, Suh YA, Liu G, Rao VA, Parant JM, Valentin-Vega YA, Terzian T, Caldwell LC, Strong LC, El-Naggar AK, Lozano G. Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome. Cell. 2004 Dec 17; 119(6):861-72. PMID: 15607981.
      View in: PubMed
    66. Bond GL, Hu W, Bond EE, Robins H, Lutzker SG, Arva NC, Bargonetti J, Bartel F, Taubert H, Wuerl P, Onel K, Yip L, Hwang SJ, Strong LC, Lozano G, Levine AJ. A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell. 2004 Nov 24; 119(5):591-602. PMID: 15550242.
      View in: PubMed
    67. Barlow JW, Mous M, Wiley JC, Varley JM, Lozano G, Strong LC, Malkin D. Germ line BAX alterations are infrequent in Li-Fraumeni syndrome. Cancer Epidemiol Biomarkers Prev. 2004 Aug; 13(8):1403-6. PMID: 15298965.
      View in: PubMed
    68. Gold D, Coombes K, Medhane D, Ramaswamy A, Ju Z, Strong L, Koo JS, Kapoor M. A comparative analysis of data generated using two different target preparation methods for hybridization to high-density oligonucleotide microarrays. BMC Genomics. 2004 Jan 06; 5(1):2. PMID: 14709180.
      View in: PubMed
    69. Wong SS, Lozano G, Gaff CL, Gardner RJ, Strong LC, Aittomäki K, Lindeman GJ. Novel p53 germline mutation in a patient with Li-Fraumeni syndrome. Intern Med J. 2003 Dec; 33(12):621. PMID: 14656244.
      View in: PubMed
    70. Strong LC. The two-hit model for Wilms' tumor: where are we 30 years later? Genes Chromosomes Cancer. 2003 Dec; 38(4):294-9. PMID: 14566846.
      View in: PubMed
    71. Kadan-Lottick NS, Friedman DL, Mertens AC, Whitton JA, Yasui Y, Strong LC, Robison LL. Self-reported family history of cancer: the utility of probing questions. Epidemiology. 2003 Nov; 14(6):737-40. PMID: 14569191.
      View in: PubMed
    72. Hwang SJ, Cheng LS, Lozano G, Amos CI, Gu X, Strong LC. Lung cancer risk in germline p53 mutation carriers: association between an inherited cancer predisposition, cigarette smoking, and cancer risk. Hum Genet. 2003 Aug; 113(3):238-43. PMID: 12802680.
      View in: PubMed
    73. Hwang SJ, Lozano G, Amos CI, Strong LC. Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk. Am J Hum Genet. 2003 Apr; 72(4):975-83. PMID: 12610779.
      View in: PubMed
    74. Chao LY, Mishra R, Strong LC, Saunders GF. Missense mutations in the DNA-binding region and termination codon in PAX6. Hum Mutat. 2003 Feb; 21(2):138-45. PMID: 12552561.
      View in: PubMed
    75. Strong LC. General keynote: hereditary cancer: lessons from Li-Fraumeni syndrome. Gynecol Oncol. 2003 Jan; 88(1 Pt 2):S4-7; discussion S11-3. PMID: 12586075.
      View in: PubMed
    76. Anton-Culver H, Ziogas A, Bowen D, Finkelstein D, Griffin C, Hanson J, Isaacs C, Kasten-Sportes C, Mineau G, Nadkarni P, Rimer B, Schildkraut J, Strong L, Weber B, Winn D, Hiatt R, Nayfield S. The Cancer Genetics Network: recruitment results and pilot studies. Community Genet. 2003; 6(3):171-7. PMID: 15237201.
      View in: PubMed
    77. Veltman IM, Schepens MT, Looijenga LH, Strong LC, van Kessel AG. Germ cell tumours in neonates and infants: a distinct subgroup? APMIS. 2003 Jan; 111(1):152-60; discussion 160. PMID: 12752256.
      View in: PubMed
    78. Robison LL, Mertens AC, Boice JD, Breslow NE, Donaldson SS, Green DM, Li FP, Meadows AT, Mulvihill JJ, Neglia JP, Nesbit ME, Packer RJ, Potter JD, Sklar CA, Smith MA, Stovall M, Strong LC, Yasui Y, Zeltzer LK. Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project. Med Pediatr Oncol. 2002 Apr; 38(4):229-39. PMID: 11920786.
      View in: PubMed
    79. Lott ST, Chandler DS, Curley SA, Foster CJ, El-Naggar A, Frazier M, Strong LC, Lovell M, Killary AM. High frequency loss of heterozygosity in von Hippel-Lindau (VHL)-associated and sporadic pancreatic islet cell tumors: evidence for a stepwise mechanism for malignant conversion in VHL tumorigenesis. Cancer Res. 2002 Apr 01; 62(7):1952-5. PMID: 11929809.
      View in: PubMed
    80. Shete S, Amos CI, Hwang SJ, Strong LC. Individual-specific liability groups in genetic linkage, with applications to kindreds with Li-Fraumeni syndrome. Am J Hum Genet. 2002 Mar; 70(3):813-7. PMID: 11822026.
      View in: PubMed
    81. Breslow NE, Takashima JR, Ritchey ML, Strong LC, Green DM. Renal failure in the Denys-Drash and Wilms' tumor-aniridia syndromes. Cancer Res. 2000 Aug 01; 60(15):4030-2. PMID: 10945603.
      View in: PubMed
    82. Chao LY, Huff V, Strong LC, Saunders GF. Mutation in the PAX6 gene in twenty patients with aniridia. Hum Mutat. 2000; 15(4):332-9. PMID: 10737978.
      View in: PubMed
    83. Mihich E, Strong L, Klausner R. Tenth Annual Pezcoller Symposium: the genetics of cancer susceptibility. Cancer Res. 1999 Jul 01; 59(13):3271-9. PMID: 10397276.
      View in: PubMed
    84. Hung J, Mims B, Lozano G, Strong L, Harvey C, Chen TT, Stastny V, Tomlinson G. TP53 mutation and haplotype analysis of two large African American families. Hum Mutat. 1999; 14(3):216-21. PMID: 10477429.
      View in: PubMed
    85. Rahman N, Abidi F, Ford D, Arbour L, Rapley E, Tonin P, Barton D, Batcup G, Berry J, Cotter F, Davison V, Gerrard M, Gray E, Grundy R, Hanafy M, King D, Lewis I, Ridolfi Luethy A, Madlensky L, Mann J, O'Meara A, Oakhill T, Skolnick M, Strong L, Stratton MR, et al. Confirmation of FWT1 as a Wilms' tumour susceptibility gene and phenotypic characteristics of Wilms' tumour attributable to FWT1. Hum Genet. 1998 Nov; 103(5):547-56. PMID: 9860296.
      View in: PubMed
    86. Gollahon LS, Kraus E, Wu TA, Yim SO, Strong LC, Shay JW, Tainsky MA. Telomerase activity during spontaneous immortalization of Li-Fraumeni syndrome skin fibroblasts. Oncogene. 1998 Aug 13; 17(6):709-17. PMID: 9715272.
      View in: PubMed
    87. Frank TS, Manley SA, Olopade OI, Cummings S, Garber JE, Bernhardt B, Antman K, Russo D, Wood ME, Mullineau L, Isaacs C, Peshkin B, Buys S, Venne V, Rowley PT, Loader S, Offit K, Robson M, Hampel H, Brener D, Winer EP, Clark S, Weber B, Strong LC, Thomas A, et al. Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J Clin Oncol. 1998 Jul; 16(7):2417-25. PMID: 9667259.
      View in: PubMed
    88. Evans SC, Mims B, McMasters KM, Foster CJ, deAndrade M, Amos CI, Strong LC, Lozano G. Exclusion of a p53 germline mutation in a classic Li-Fraumeni syndrome family. Hum Genet. 1998 Jun; 102(6):681-6. PMID: 9703430.
      View in: PubMed
    89. Kraus E, Strong LC, Tainsky MA. pZ402, an improved SV40-based shuttle vector containing a T-antigen mutant unable to interact with wild-type p53. Gene. 1998 May 12; 211(2):229-34. PMID: 9602136.
      View in: PubMed
    90. McDonald JM, Douglass EC, Fisher R, Geiser CF, Krill CE, Strong LC, Virshup D, Huff V. Linkage of familial Wilms' tumor predisposition to chromosome 19 and a two-locus model for the etiology of familial tumors. Cancer Res. 1998 Apr 01; 58(7):1387-90. PMID: 9537236.
      View in: PubMed
    91. Byrne J, Rasmussen SA, Steinhorn SC, Connelly RR, Myers MH, Lynch CF, Flannery J, Austin DF, Holmes FF, Holmes GE, Strong LC, Mulvihill JJ. Genetic disease in offspring of long-term survivors of childhood and adolescent cancer. Am J Hum Genet. 1998 Jan; 62(1):45-52. PMID: 9443870.
      View in: PubMed
    92. Luca JW, Strong LC, Hansen MF. A germline missense mutation R337C in exon 10 of the human p53 gene. Hum Mutat. 1998; Suppl 1:S58-61. PMID: 9452042.
      View in: PubMed
    93. Schubert EL, Strong LC, Hansen MF. A splicing mutation in RB1 in low penetrance retinoblastoma. Hum Genet. 1997 Oct; 100(5-6):557-63. PMID: 9341870.
      View in: PubMed
    94. Ayan I, Luca J, Jaffe N, Strong L, Hansen M. De novo germline mutations of the p53 gene in young children with sarcomas. Oncol Rep. 1997 Jul-Aug; 4(4):679-83. PMID: 21590121.
      View in: PubMed
    95. Huff V, Amos CI, Douglass EC, Fisher R, Geiser CF, Krill CE, Li FP, Strong LC, McDonald JM. Evidence for genetic heterogeneity in familial Wilms' tumor. Cancer Res. 1997 May 15; 57(10):1859-62. PMID: 9157975.
      View in: PubMed
    96. Malkin D, Friend SH, Li FP, Strong LC. Germ-line mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. N Engl J Med. 1997 Mar 06; 336(10):734. PMID: 9045054.
      View in: PubMed
    97. Kruzelock RP, Murphy EC, Strong LC, Naylor SL, Hansen MF. Localization of a novel tumor suppressor locus on human chromosome 3q important in osteosarcoma tumorigenesis. Cancer Res. 1997 Jan 01; 57(1):106-9. PMID: 8988049.
      View in: PubMed
    98. Hecht JT, Hogue D, Wang Y, Blanton SH, Wagner M, Strong LC, Raskind W, Hansen MF, Wells D. Hereditary multiple exostoses (EXT): mutational studies of familial EXT1 cases and EXT-associated malignancies. Am J Hum Genet. 1997 Jan; 60(1):80-6. PMID: 8981950.
      View in: PubMed
    99. Gunning KB, Cohn SL, Tomlinson GE, Strong LC, Huff V. Analysis of possible WT1 RNA processing in primary Wilms tumors. Oncogene. 1996 Sep 19; 13(6):1179-85. PMID: 8808692.
      View in: PubMed
    100. Liu PK, Kraus E, Wu TA, Strong LC, Tainsky MA. Analysis of genomic instability in Li-Fraumeni fibroblasts with germline p53 mutations. Oncogene. 1996 Jun 06; 12(11):2267-78. PMID: 8649766.
      View in: PubMed
    101. Priest JR, Watterson J, Strong L, Huff V, Woods WG, Byrd RL, Friend SH, Newsham I, Amylon MD, Pappo A, Mahoney DH, Langston C, Heyn R, Kohut G, Freyer DR, Bostrom B, Richardson MS, Barredo J, Dehner LP. Pleuropulmonary blastoma: a marker for familial disease. J Pediatr. 1996 Feb; 128(2):220-4. PMID: 8636815.
      View in: PubMed
    102. Lowden JA. Certificates of confidentiality. Am J Hum Genet. 1996 Feb; 58(2):436-8. PMID: 8571974.
      View in: PubMed
    103. Earley CL, Strong LC. Certificates of confidentiality: a valuable tool for protecting genetic data. Am J Hum Genet. 1995 Sep; 57(3):727-31. PMID: 7668302.
      View in: PubMed
    104. Rong S, Donehower LA, Hansen MF, Strong L, Tainsky M, Jeffers M, Resau JH, Hudson E, Tsarfaty I, Vande Woude GF. Met proto-oncogene product is overexpressed in tumors of p53-deficient mice and tumors of Li-Fraumeni patients. Cancer Res. 1995 May 01; 55(9):1963-70. PMID: 7728766.
      View in: PubMed
    105. Hecht JT, Hogue D, Strong LC, Hansen MF, Blanton SH, Wagner M. Hereditary multiple exostosis and chondrosarcoma: linkage to chromosome II and loss of heterozygosity for EXT-linked markers on chromosomes II and 8. Am J Hum Genet. 1995 May; 56(5):1125-31. PMID: 7726168.
      View in: PubMed
    106. Tainsky MA, Bischoff FZ, Strong LC. Genomic instability due to germline p53 mutations drives preneoplastic progression toward cancer in human cells. Cancer Metastasis Rev. 1995 Mar; 14(1):43-8. PMID: 7606820.
      View in: PubMed
    107. Huff V, Jaffe N, Saunders GF, Strong LC, Villalba F, Ruteshouser EC. WT1 exon 1 deletion/insertion mutations in Wilms tumor patients, associated with di- and trinucleotide repeats and deletion hotspot consensus sequences. Am J Hum Genet. 1995 Jan; 56(1):84-90. PMID: 7825606.
      View in: PubMed
    108. Martha A, Strong LC, Ferrell RE, Saunders GF. Three novel aniridia mutations in the human PAX6 gene. Hum Mutat. 1995; 6(1):44-9. PMID: 7550230.
      View in: PubMed
    109. Strong LC, Marteau T. Evaluating children and adolescents for heritable cancer risk. J Natl Cancer Inst Monogr. 1995; (17):111-3. PMID: 8573442.
      View in: PubMed
    110. Martinerie C, Huff V, Joubert I, Badzioch M, Saunders G, Strong L, Perbal B. Structural analysis of the human nov proto-oncogene and expression in Wilms tumor. Oncogene. 1994 Sep; 9(9):2729-32. PMID: 7520150.
      View in: PubMed
    111. Schubert EL, Hansen MF, Strong LC. The retinoblastoma gene and its significance. Ann Med. 1994 Jun; 26(3):177-84. PMID: 8074836.
      View in: PubMed
    112. Naumova A, Hansen M, Strong L, Jones PA, Hadjistilianou D, Mastrangelo D, Griegel S, Rajewsky MF, Shields J, Donoso L, et al. Concordance between parental origin of chromosome 13q loss and chromosome 6p duplication in sporadic retinoblastoma. Am J Hum Genet. 1994 Feb; 54(2):274-81. PMID: 8304344.
      View in: PubMed
    113. Bondy ML, Strom SS, Colopy MW, Brown BW, Strong LC. Accuracy of family history of cancer obtained through interviews with relatives of patients with childhood sarcoma. J Clin Epidemiol. 1994 Jan; 47(1):89-96. PMID: 8283198.
      View in: PubMed
    114. Smith MB, Xue H, Strong L, Takahashi H, Jaffe N, Ried H, Zietz H, Andrassy RJ. Forty-year experience with second malignancies after treatment of childhood cancer: analysis of outcome following the development of the second malignancy. J Pediatr Surg. 1993 Oct; 28(10):1342-8; discussion 1348-9. PMID: 8263699.
      View in: PubMed
    115. Strong LC. Genetic implications for long-term survivors of childhood cancer. Cancer. 1993 May 15; 71(10 Suppl):3435-40. PMID: 8387878.
      View in: PubMed
    116. Meadows AT, Black B, Nesbit ME, Strong LC, Nicholson HS, Green DM, Hays DM, Lozowski SL. Long-term survival. Clinical care, research, and education. Cancer. 1993 May 15; 71(10 Suppl):3213-5. PMID: 8490854.
      View in: PubMed
    117. Chao LY, Huff V, Tomlinson G, Riccardi VM, Strong LC, Saunders GF. Genetic mosaicism in normal tissues of Wilms' tumour patients. Nat Genet. 1993 Feb; 3(2):127-31. PMID: 8388768.
      View in: PubMed
    118. Troilo P, Strong LC, Little JB, Nichols WW. Spontaneous and induced levels of chromosomal aberration and sister-chromatid exchange in neurofibromatosis: no evidence of chromosomal hypersensitivity. Mutat Res. 1992 Dec; 283(4):237-42. PMID: 1383795.
      View in: PubMed
    119. Huff V, Reeve AE, Leppert M, Strong LC, Douglass EC, Geiser CF, Li FP, Meadows A, Callen DF, Lenoir G, et al. Nonlinkage of 16q markers to familial predisposition to Wilms' tumor. Cancer Res. 1992 Nov 01; 52(21):6117-20. PMID: 1356625.
      View in: PubMed
    120. Yin Y, Tainsky MA, Bischoff FZ, Strong LC, Wahl GM. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell. 1992 Sep 18; 70(6):937-48. PMID: 1525830.
      View in: PubMed
    121. Li FP, Garber JE, Friend SH, Strong LC, Patenaude AF, Juengst ET, Reilly PR, Correa P, Fraumeni JF. Recommendations on predictive testing for germ line p53 mutations among cancer-prone individuals. J Natl Cancer Inst. 1992 Aug 05; 84(15):1156-60. PMID: 1635084.
      View in: PubMed
    122. Lustbader ED, Williams WR, Bondy ML, Strom S, Strong LC. Segregation analysis of cancer in families of childhood soft-tissue-sarcoma patients. Am J Hum Genet. 1992 Aug; 51(2):344-56. PMID: 1642235.
      View in: PubMed
    123. Malkin D, Jolly KW, Barbier N, Look AT, Friend SH, Gebhardt MC, Andersen TI, Børresen AL, Li FP, Garber J, et al. Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. N Engl J Med. 1992 May 14; 326(20):1309-15. PMID: 1565144.
      View in: PubMed
    124. Byrne J, Fears TR, Gail MH, Pee D, Connelly RR, Austin DF, Holmes GF, Holmes FF, Latourette HB, Meigs JW, et al. Early menopause in long-term survivors of cancer during adolescence. Am J Obstet Gynecol. 1992 Mar; 166(3):788-93. PMID: 1550144.
      View in: PubMed
    125. Miwa H, Tomlinson GE, Timmons CF, Huff V, Cohn SL, Strong LC, Saunders GF. RNA expression of the WT1 gene in Wilms' tumors in relation to histology. J Natl Cancer Inst. 1992 Feb 05; 84(3):181-7. PMID: 1311774.
      View in: PubMed
    126. Strong LC, Williams WR, Tainsky MA. The Li-Fraumeni syndrome: from clinical epidemiology to molecular genetics. Am J Epidemiol. 1992 Jan 15; 135(2):190-9. PMID: 1536134.
      View in: PubMed
    127. Haupt R, Byrne J, Connelly RR, Mostow EN, Austin DF, Holmes GR, Holmes FF, Latourette HB, Teta MJ, Strong LC, et al. Smoking habits in survivors of childhood and adolescent cancer. Med Pediatr Oncol. 1992; 20(4):301-6. PMID: 1608351.
      View in: PubMed
    128. Bondy ML, Lustbader ED, Strom SS, Strong LC. Segregation analysis of 159 soft tissue sarcoma kindreds: comparison of fixed and sequential sampling schemes. Genet Epidemiol. 1992; 9(5):291-304. PMID: 1427019.
      View in: PubMed
    129. Ton CC, Hirvonen H, Miwa H, Weil MM, Monaghan P, Jordan T, van Heyningen V, Hastie ND, Meijers-Heijboer H, Drechsler M, et al. Positional cloning and characterization of a paired box- and homeobox-containing gene from the aniridia region. Cell. 1991 Dec 20; 67(6):1059-74. PMID: 1684738.
      View in: PubMed
    130. Law JC, Strong LC, Chidambaram A, Ferrell RE. A germ line mutation in exon 5 of the p53 gene in an extended cancer family. Cancer Res. 1991 Dec 01; 51(23 Pt 1):6385-7. PMID: 1933902.
      View in: PubMed
    131. Schwartz CE, Haber DA, Stanton VP, Strong LC, Skolnick MH, Housman DE. Familial predisposition to Wilms tumor does not segregate with the WT1 gene. Genomics. 1991 Aug; 10(4):927-30. PMID: 1655633.
      View in: PubMed
    132. Olschwang S, Weiffenbach B, Laurent-Puig P, Melot T, Vassal A, Falls K, Salmon RJ, Parc R, Strong L, Nakamura Y, et al. Genetic characterization of the APC locus involved in familial adenomatous polyposis. Gastroenterology. 1991 Jul; 101(1):154-60. PMID: 1646139.
      View in: PubMed
    133. Haddad FS. Re: Familial renal cell carcinoma: hereditary or coincidental? J Urol. 1991 Jul; 146(1):168. PMID: 2056584.
      View in: PubMed
    134. Huff V, Miwa H, Haber DA, Call KM, Housman D, Strong LC, Saunders GF. Evidence for WT1 as a Wilms tumor (WT) gene: intragenic germinal deletion in bilateral WT. Am J Hum Genet. 1991 May; 48(5):997-1003. PMID: 1673293.
      View in: PubMed
    135. Ton CC, Huff V, Call KM, Cohn S, Strong LC, Housman DE, Saunders GF. Smallest region of overlap in Wilms tumor deletions uniquely implicates an 11p13 zinc finger gene as the disease locus. Genomics. 1991 May; 10(1):293-7. PMID: 1646159.
      View in: PubMed
    136. Tomlinson GE, Compton DA, Strong LC, Saunders GF. PCR detection of a BglII RFLP at 11p13. Nucleic Acids Res. 1991 Apr 11; 19(7):1718. PMID: 1674135.
      View in: PubMed
    137. Strong LC. Genetic implications for long-term survivors of childhood cancer. J Pediatr Oncol Nurs. 1991 Apr; 8(2):57-8. PMID: 1675064.
      View in: PubMed
    138. Bischoff FZ, Strong LC, Yim SO, Pratt DR, Siciliano MJ, Giovanella BC, Tainsky MA. Tumorigenic transformation of spontaneously immortalized fibroblasts from patients with a familial cancer syndrome. Oncogene. 1991 Feb; 6(2):183-6. PMID: 2000218.
      View in: PubMed
    139. Bondy ML, Lustbader ED, Buffler PA, Schull WJ, Hardy RJ, Strong LC. Genetic epidemiology of childhood brain tumors. Genet Epidemiol. 1991; 8(4):253-67. PMID: 1756948.
      View in: PubMed
    140. Bischoff FZ, Yim SO, Pathak S, Grant G, Siciliano MJ, Giovanella BC, Strong LC, Tainsky MA. Spontaneous abnormalities in normal fibroblasts from patients with Li-Fraumeni cancer syndrome: aneuploidy and immortalization. Cancer Res. 1990 Dec 15; 50(24):7979-84. PMID: 2253239.
      View in: PubMed
    141. Malkin D, Li FP, Strong LC, Fraumeni JF, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science. 1990 Nov 30; 250(4985):1233-8. PMID: 1978757.
      View in: PubMed
    142. Levinson AK, Johnson DE, Strong LC, Pathak S, Huff V, Saunders GF. Familial renal cell carcinoma: hereditary or coincidental? J Urol. 1990 Oct; 144(4):849-51. PMID: 2398557.
      View in: PubMed
    143. Chiao PJ, Bischoff FZ, Strong LC, Tainsky MA. The current state of oncogenes and cancer: experimental approaches for analyzing oncogenetic events in human cancer. Cancer Metastasis Rev. 1990 Jul; 9(1):63-80. PMID: 2208569.
      View in: PubMed
    144. Huff V, Meadows A, Riccardi VM, Strong LC, Saunders GF. Parental origin of de novo constitutional deletions of chromosomal band 11p13. Am J Hum Genet. 1990 Jul; 47(1):155-60. PMID: 1971994.
      View in: PubMed
    145. Selvanayagam P, Strong LC, Saunders GF, Barlogie B. A rare BclI RFLP in the putative oncogene bcl-1 locus. Nucleic Acids Res. 1990 Mar 25; 18(6):1665. PMID: 1970177.
      View in: PubMed
    146. Chidambaram A, Strong LC, Ferrell RE. A new, low frequency MspI allele at the D13S3 locus. Nucleic Acids Res. 1990 Mar 11; 18(5):1317. PMID: 1690877.
      View in: PubMed
    147. Ton CC, Huff V, Weil MM, Strong LC, Saunders GF. A BglII RFLP detected by the probe JA8-1 at human chromosome band 11p13 (D11S417). Nucleic Acids Res. 1990 Feb 25; 18(4):1084. PMID: 1969141.
      View in: PubMed
    148. Weil MM, Huff V, Compton DA, Strong LC, Saunders GF. An XmnI polymorphism detected by a human genomic clone from chromosomal band 11p13 [D11S416]. Nucleic Acids Res. 1990 Feb 11; 18(3):689. PMID: 1968626.
      View in: PubMed
    149. Compton DA, Weil MM, Bonetta L, Huang A, Jones C, Yeger H, Williams BR, Strong LC, Saunders GF. Definition of the limits of the Wilms tumor locus on human chromosome 11p13. Genomics. 1990 Feb; 6(2):309-15. PMID: 2155176.
      View in: PubMed
    150. Huff V, Compton DA, Strong LC, Saunders GF. A panel of restriction fragment length polymorphisms for chromosomal band 11p13. Hum Genet. 1990 Feb; 84(3):253-7. PMID: 1968033.
      View in: PubMed
    151. Byrne J, Fears TR, Steinhorn SC, Mulvihill JJ, Connelly RR, Austin DF, Holmes GF, Holmes FF, Latourette HB, Teta MJ, et al. Marriage and divorce after childhood and adolescent cancer. JAMA. 1989 Nov 17; 262(19):2693-9. PMID: 2810602.
      View in: PubMed
    152. Little JB, Nichols WW, Troilo P, Nagasawa H, Strong LC. Radiation sensitivity of cell strains from families with genetic disorders predisposing to radiation-induced cancer. Cancer Res. 1989 Sep 01; 49(17):4705-14. PMID: 2758405.
      View in: PubMed
    153. Strong LC, Williams WR, Ferrell RE, Tainsky MA. Genetic analysis of childhood sarcoma. Princess Takamatsu Symp. 1989; 20:151-7. PMID: 2488230.
      View in: PubMed
    154. Garber JE, Li FP, Kingston JE, Krush AJ, Strong LC, Finegold MJ, Bertario L, Bülow S, Filippone A, Gedde-Dahl T, et al. Hepatoblastoma and familial adenomatous polyposis. J Natl Cancer Inst. 1988 Dec 21; 80(20):1626-8. PMID: 2848134.
      View in: PubMed
    155. Compton DA, Weil MM, Jones C, Riccardi VM, Strong LC, Saunders GF. Long range physical map of the Wilms' tumor-aniridia region on human chromosome 11. Cell. 1988 Dec 02; 55(5):827-36. PMID: 2847871.
      View in: PubMed
    156. Little JB, Nove J, Strong LC, Nichols WW. Survival of human diploid skin fibroblasts from normal individuals after X-irradiation. Int J Radiat Biol. 1988 Dec; 54(6):899-910. PMID: 2903888.
      View in: PubMed
    157. Huff V, Compton DA, Chao LY, Strong LC, Geiser CF, Saunders GF. Lack of linkage of familial Wilms' tumour to chromosomal band 11p13. Nature. 1988 Nov 24; 336(6197):377-8. PMID: 2848200.
      View in: PubMed
    158. Lyons LA, Lewis RA, Strong LC, Zuckerbrod S, Ferrell RE. A genetic study of Gardner syndrome and congenital hypertrophy of the retinal pigment epithelium. Am J Hum Genet. 1988 Feb; 42(2):290-6. PMID: 3422541.
      View in: PubMed
    159. Kelaghan J, Myers MH, Mulvihill JJ, Byrne J, Connelly RR, Austin DF, Strong LC, Meigs JW, Latourette HB, Holmes GF, et al. Educational achievement of long-term survivors of childhood and adolescent cancer. Med Pediatr Oncol. 1988; 16(5):320-6. PMID: 3185360.
      View in: PubMed
    160. Byrne J, Mulvihill JJ, Connelly RR, Austin DA, Holmes GE, Holmes FF, Latourette HB, Meigs JW, Strong LC, Myers MH. Reproductive problems and birth defects in survivors of Wilms' tumor and their relatives. Med Pediatr Oncol. 1988; 16(4):233-40. PMID: 2843733.
      View in: PubMed
    161. Strong LC, Stine M, Norsted TL. Cancer in survivors of childhood soft tissue sarcoma and their relatives. J Natl Cancer Inst. 1987 Dec; 79(6):1213-20. PMID: 3480372.
      View in: PubMed
    162. Byrne J, Mulvihill JJ, Myers MH, Connelly RR, Naughton MD, Krauss MR, Steinhorn SC, Hassinger DD, Austin DF, Bragg K, et al. Effects of treatment on fertility in long-term survivors of childhood or adolescent cancer. N Engl J Med. 1987 Nov 19; 317(21):1315-21. PMID: 3683460.
      View in: PubMed
    163. Mulvihill JJ, Myers MH, Connelly RR, Byrne J, Austin DF, Bragg K, Cook JW, Hassinger DD, Holmes FF, Holmes GF, et al. Cancer in offspring of long-term survivors of childhood and adolescent cancer. Lancet. 1987 Oct 10; 2(8563):813-7. PMID: 2889030.
      View in: PubMed
    164. Huff V, Compton D, Lewis W, Jones C, Strong LC, Saunders GF. An EcoRI polymorphism associated with a human genomic clone from band 11p13. Nucleic Acids Res. 1987 Sep 25; 15(18):7651. PMID: 2889190.
      View in: PubMed
    165. Tucker MA, D'Angio GJ, Boice JD, Strong LC, Li FP, Stovall M, Stone BJ, Green DM, Lombardi F, Newton W, et al. Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med. 1987 Sep 03; 317(10):588-93. PMID: 3475572.
      View in: PubMed
    166. Little JB, Nove J, Dahlberg WK, Troilo P, Nichols WW, Strong LC. Normal cytotoxic response of skin fibroblasts from patients with Li-Fraumeni familial cancer syndrome to DNA-damaging agents in vitro. Cancer Res. 1987 Aug 01; 47(15):4229-34. PMID: 3111682.
      View in: PubMed
    167. Dao DD, Schroeder WT, Chao LY, Kikuchi H, Strong LC, Riccardi VM, Pathak S, Nichols WW, Lewis WH, Saunders GF. Genetic mechanisms of tumor-specific loss of 11p DNA sequences in Wilms tumor. Am J Hum Genet. 1987 Aug; 41(2):202-17. PMID: 3039839.
      View in: PubMed
    168. Craig-Holmes AP, Strong LC, Goodacre A, Pathak S. Variation in the expression of aphidicolin-induced fragile sites in human lymphocyte cultures. Hum Genet. 1987 Jun; 76(2):134-7. PMID: 3111974.
      View in: PubMed
    169. Strong LC, Williams WR. The genetic implications of long-term survival of childhood cancer. A conceptual framework. Am J Pediatr Hematol Oncol. 1987; 9(1):99-103. PMID: 3592122.
      View in: PubMed
    170. Strong LC, Herson J, Haas C, Elder K, Chakraborty R, Weiss KM, Majumder P. Cancer mortality in relatives of retinoblastoma patients. J Natl Cancer Inst. 1984 Aug; 73(2):303-11. PMID: 6589425.
      View in: PubMed
    171. Raum D, Awdeh Z, Glass D, Kammer G, Khan MA, Coblyn JS, Weinblatt M, Holdsworth D, Strong L, Rossen RD, et al. Extended haplotypes of chromosome 6 in adult rheumatoid arthritis. Arthritis Rheum. 1984 May; 27(5):516-21. PMID: 6586181.
      View in: PubMed
    172. DiMaio SM, Strong LC, Ford RJ, Ayala AG. Double primary malignancies: osteosarcoma and medulloblastoma. South Med J. 1984 Mar; 77(3):388-90. PMID: 6583849.
      View in: PubMed
    173. Bale SJ, Chakravarti A, Strong LC. Aggregation of colon cancer in family data. Genet Epidemiol. 1984; 1(1):53-61. PMID: 6544232.
      View in: PubMed
    174. Cavenee WK, Dryja TP, Phillips RA, Benedict WF, Godbout R, Gallie BL, Murphree AL, Strong LC, White RL. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature. 1983 Oct 27-Nov 2; 305(5937):779-84. PMID: 6633649.
      View in: PubMed
    175. van Tuinen P, Strong LC, Pathak S. Reduced NOR association frequency in a 13/18 translocation chromosome. A family study. Hum Genet. 1983; 65(1):82-4. PMID: 6642511.
      View in: PubMed
    176. Pathak S, Strong LC, Ferrell RE, Trindade A. Familial renal cell carcinoma with a 3;11 chromosome translocation limited to tumor cells. Science. 1982 Sep 03; 217(4563):939-41. PMID: 7112106.
      View in: PubMed
    177. Parry DM, Li FP, Strong LC, Carney JA, Schottenfeld D, Reimer RR, Grufferman S. Carotid body tumors in humans: genetics and epidemiology. J Natl Cancer Inst. 1982 Apr; 68(4):573-8. PMID: 6951072.
      View in: PubMed
    178. Riccardi VM, Hittner HM, Strong LC, Fernbach DJ, Lebo R, Ferrell RE. Wilms tumor with aniridia/iris dysplasia and apparently normal chromosomes. J Pediatr. 1982 Apr; 100(4):574-7. PMID: 6278119.
      View in: PubMed
    179. Strong LC, Riccardi VM, Ferrell RE, Sparkes RS. Familial retinoblastoma and chromosome 13 deletion transmitted via an insertional translocation. Science. 1981 Sep 25; 213(4515):1501-3. PMID: 7280668.
      View in: PubMed
    180. Meadows AT, Strong LC, Li FP, D'Angio GJ, Schweisguth O, Freeman AI, Jenkin RD, Morris-Jones P, Nesbit ME. Bone sarcoma as a second malignant neoplasm in children: influence of radiation and genetic predisposition for the Late Effects Study Group. Cancer. 1980 Dec 15; 46(12):2603-6. PMID: 7448699.
      View in: PubMed
    181. Hittner HM, Riccardi VM, Ferrell RE, Strobel RJ, Ledbetter DH, Strong L, Lebo R. Genetic heterogeneity of aniridia: negative linkage data. Metab Pediatr Ophthalmol. 1980; 4(4):179-82. PMID: 6259463.
      View in: PubMed
    182. Strong LC, Herson J, Osborne BM, Sutow WW. Risk of radiation-related subsequent malignant tumors in survivors of Ewing's sarcoma. J Natl Cancer Inst. 1979 Jun; 62(6):1401-6. PMID: 220452.
      View in: PubMed
    183. Strong LC. Genetically susceptible subgroups. Environ Health Perspect. 1978 Feb; 22:139-40. PMID: 648477.
      View in: PubMed
    184. Strong LC. Genetic and environmental interactions. Cancer. 1977 Oct; 40(4 Suppl):1861-6. PMID: 332332.
      View in: PubMed
    185. Strong LC. Genetic etiology of cancer. Cancer. 1977 Jul; 40(1 Suppl):438-44. PMID: 328131.
      View in: PubMed
    186. Rivera R, Cangir A, Strong L. Incontinentia pigmenti (Bloch-Sulzberger syndrome) associated with acute granulocytic leukemia. South Med J. 1975 Nov; 68(11):1391-4. PMID: 1059263.
      View in: PubMed
    187. Knudson AG, Strong LC. Letter: Familial Wilms's tumor. Am J Hum Genet. 1975 Nov; 27(6):809-10. PMID: 173187.
      View in: PubMed
    188. Strong LC, Knudson AG. Letter: Second cancers in retinoblastoma. Lancet. 1973 Nov 10; 2(7837):1086. PMID: 4127339.
      View in: PubMed
    189. Knudson AG, Strong LC, Anderson DE. Heredity and cancer in man. Prog Med Genet. 1973; 9:113-58. PMID: 4351406.
      View in: PubMed
    190. Knudson AG, Strong LC. Mutation and cancer: neuroblastoma and pheochromocytoma. Am J Hum Genet. 1972 Sep; 24(5):514-32. PMID: 4340974.
      View in: PubMed
    191. Knudson AG, Strong LC. Mutation and cancer: a model for Wilms' tumor of the kidney. J Natl Cancer Inst. 1972 Feb; 48(2):313-24. PMID: 4347033.
      View in: PubMed
    192. STRONG LC, IDDLES A. Bowen's disease of the skin. Associated with squamous cell carcinoma of the skin, with metastasis to the axillary lymph nodes. A case report. Del Med J. 1950 Oct; 22(10):302-4. PMID: 14778324.
      View in: PubMed
    193. Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocol. Annals of Oncology. 27:795-800.
    194. Breast cancer risk in childhood cancer survivors without a history of chest radiotherapy. Journal of Clinical Oncology. 34:910-918.
    195. Functional characterization of inherited p53 mutations. Cancer Bulletin. 46:247-253.
    196. Erratum. Cancer. 118:2561.
    197. Mosaic sex chromosome constitution in a patient with Klinefelter's syndrome who developed metastatic sarcoma of the lung. Revista Brasileira de Genetica. 12:843-857.
    198. Effects of MDM2, MDM4and TP53 codon 72 polymorphisms on cancer risk in a cohort study of carriers of TP53 germline mutations. PLoS One. 5.
    199. Genetic epidemiology of childhood soft tissue sarcoma (STS).
    200. Identification of germline DICER1 mutations and loss of heterozygosity in familial Wilms tumour. Journal of Medical Genetics. 53:385-388.
    201. Erratum. New England Journal of Medicine. 336:734.
    202. Genetic factors and their role in detection of cancer. Cancer Detection and Prevention. 2:5-19.
    203. Familial retinoblastoma and chromosome 13 deletion transmitted via an insertional translocation. Science. 213:1503-1505.
    204. PROCEEDINGS, XI INTERNATIONAL CANCER CONGRESS, FLORENCE 1974. 267-271.
    205. Monitoring late effects of therapy in clinical trials. Controlled Clinical Trials. 2:81.
    206. The medical minefield that is Li-Fraumeni syndrome. Community Oncology. 6:517-518.
    STRONG's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description